PATENT CLAIM ANALYSIS

Application Number: 15900254
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "100000"]

Abstract:
The present invention relates generally to new chemical combinations and methods for their use in the treatment of proliferative diseases and in particular cancer.

Claim (Index 10):
The method according to  claim 1 , wherein (a) and (b) are separately administered as a single dose within 48 hours of each other and (a) is administered again at least two further times after at least about 96 hours from the first dose in a 28 day cycle.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.08696
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13392473', '12671287', '14409042', '15301522', '15141170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7581501039802442
- 35 USC 102 Novelty (BERT): 0.521004369260491
- Combined Prediction Score: 0.7344355305082688
- Mean Citation Score: 198.257444
- Max Citation Score: 229.95848
- Similarity Product: 116.27648683649063

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test